Clinical Trial Update: A Study of KY1005 in Patients With Moderate to Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating KY1005 in patients with moderate to severe atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• KY1005

Snippet

Sponsor: Kymab Limited | Conditions: Dermatitis, Atopic | Phase 2 | Status: COMPLETED